What Pharmadule does

Pharmadule Morimatsu AB, founded in Stockholm in 1986, is a Swedish-headquartered engineering and construction firm that pioneered the modular delivery concept for pharmaceutical manufacturing facilities. The company prefabricates building modules and integrated process/utility systems in controlled factory environments — primarily its Suzhou plant (~70,000 sqm, 17m free height, 100-ton lifting capacity) and Nantong plant (~160,000 sqm with private dock for direct ship/barge loading) — then ships them worldwide for site assembly, commissioning, qualification, and handover. Approximately 75-80% of facility work is completed in the workshop before shipping, compressing delivery by 3-12 months versus conventional construction. The platform comprises Modular Facilities (complete buildings), Process Modules (bioreactors, fermenters, buffer prep, purification, formulation, CIP systems via 'Extreme Modularization'), and Indoor Modules (in-building GMP retrofits), supported by Front-End Design, Commissioning/Qualification/Validation, and After-Sales services.

Pharmadule serves global pharmaceutical, biopharmaceutical, ATMP (cell/gene therapy), traditional pharma, and FMCG manufacturers through a direct enterprise sales model, with named clients including Eli Lilly, Merck/MSD, GSK, Lonza, EIPICO, WALVAX, and Siemens Healthcare, and a reported reach to 80% of the world's top 20 pharmaceutical companies via its parent group. Revenue is generated through large, custom, project-based contracts (quote-based, pricing not publicly disclosed) recognized on project completion, supplemented by professional services and after-sales support. The company operates from 10+ global offices spanning Stockholm, New Jersey, Shanghai, Suzhou, Nantong, Yokohama, Milan, Dublin, France, India, and Malaysia.

Since 2011 Pharmadule has been a wholly-owned subsidiary of Morimatsu Group, whose ultimate parent Morimatsu International Holdings Ltd. has been publicly listed on the Hong Kong Stock Exchange (Stock Code: 2155) since June 2021. In September 2025, Morimatsu acquired Bioengineering AG (Swiss bioreactor and cultivation systems manufacturer with 50+ years of expertise), extending Pharmadule's reach upstream into bioprocessing equipment. The company holds GMP, ISO 9001, ISO 14001, and ISO 45001 certifications, is a Silver Corporate Partner of ISPE, and achieved EcoVadis Gold (top 5%) in January 2025.

Name

Pharmadule

Legal name

Pharmadule Morimatsu AB

Website

https://pharmadule.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Pharmadule designs and delivers prefabricated modular pharmaceutical manufacturing facilities for global pharma, biotech, ATMP, and FMCG companies via direct enterprise sales. Founded 1986 in Sweden, it operates as a subsidiary of Hong Kong-listed Morimatsu International Holdings (HKEx: 2155).

Ownership category

akta.pro rank

Product category

Pharmaceutical Facility Engineering & Modular Construction

NAICS

Medical Equipment and Supplies Manufacturing (3391), Analytical Laboratory Instrument Manufacturing (334516)

SIC

General Industrial Machinery & Equipment, Nec (3569)

akta.pro primary industry

Pharmaceutical & Biotech Manufacturing Facility Construction (IMAFADAI)

akta.pro secondary industries

Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH), Single-Use Systems Assembly & Consumables Manufacturing (Bags/Tubing/Assemblies) (HLAGAGAH)

Keywords

• Modular pharmaceutical facilities
• Biopharma facility engineering
• Modular construction services
• GMP turnkey delivery
• Process module fabrication

Headquarters

HQ city

Nacka

HQ country

Sweden

HQ region

Europe

Offices10 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Modular Facility Design, Fabrication & Delivery: End-to-end project-based delivery of pharmaceutical manufacturing facilities using offsite modular construction. Scope includes conceptual design, basic design, detailed design, modular fabrication, process and utility installations, shipping, site assembly, commissioning, qualification, and handover. Revenue is recognized per project upon completion and handover.
2. Process Engineering & Front-End Design Services: Front-end engineering and design services guiding clients through fast-track Front End Engineering phase including process design, conceptual design, basic design, and detailed design. Offered as standalone consulting or as part of full modular facility delivery.
3. Commissioning, Qualification & Validation Services: Commissioning, qualification, and validation (CQV) services for pharmaceutical and biopharmaceutical facilities. Includes GMP audits, GAP analysis, Validation Master Plan, Design Qualification, QMS development, and GMP consultancy and training.
4. After Sales Support & Maintenance: Post-project support including spare parts, on-site service, service contracts, documentation, training, upgrades, renovations, and warranty issues to keep facilities and equipment operational after installation and handover.
5. Sustainability Add-On Services: Customization of projects for greater environmental performance and alignment with sustainability goals including reduction of embodied carbon (low-carbon materials), preparation for environmental certification (LEED, BREEAM), and low-energy operation features.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Pharmadule designs, fabricates, and installs prefabricated modular pharmaceutical and biopharmaceutical manufacturing facilities, including complete off-site manufactured buildings, standalone process modules, and indoor modular units. The company delivers turnkey services spanning front-end engineering, modular fabrication, on-site assembly, commissioning, and cGMP qualification for drug manufacturers and CDMOs worldwide. Through the Bioengineering brand, the company also supplies stainless-steel bioreactors and fermentation systems as part of integrated facility solutions.

Product overview

Pharmadule offers a unified modular facility platform combining modular buildings with integrated process modules for pharmaceutical, biotech, and consumer products manufacturing. The core offering includes Modular Facilities (complete off-site manufactured buildings), Process Modules (individual systems like bioreactors, formulation, purification, buffer prep, CIP), and Indoor Modules (for in-building expansion). These are complemented by Front-End Design & Pre-Engineering Services, Commissioning & Qualification, and Validation & Quality Assurance Services. Bioengineering (acquired September 2025) adds bioreactor and cultivation systems to the portfolio. The Pharmadule Way delivers 75-80% of construction in controlled workshop conditions before shipping, with on-site assembly, commissioning and qualification completing the turnkey solution.

Differentiator

Problem solved

Functional benefit

Products and services

• Modular Facilities

Quantifiable outcome

• 80+ manufacturing facilities delivered worldwide since 1986
• +6 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Partnerships

Six partnerships are on record, tiered flagship, core and major.

• Bioengineering AGflagshipStrategic or Co-development Partner · 23 September 2025Bioengineering AG officially joined Morimatsu Group in September 2025, representing a significant milestone in Morimatsu LifeSciences global strategy. Bioengineering is a globally recognized R&D-driven manufacturer of high-end bioreactor and cultivation systems with over half a century of technological expertise. The acquisition strengthens Morimatsu's upstream bioprocessing value chain and competitiveness in biopharmaceutical and synthetic biology sectors.
• ISPE (International Society for Pharmaceutical Engineering)coreStrategic or Co-development Partner · 17 January 2025Pharmadule has renewed its Silver Corporate Partnership with ISPE, the leading international organization for pharmaceutical engineering professionals. The partnership supports Pharmadule's commitment to advancing pharmaceutical engineering standards and maintaining the highest industry standards. Pharmadule also exhibits at ISPE events including the ISPE Europe Annual Conference.
• EIPICO (Egyptian International Pharmaceutical Industries)coreChannel Partner/ Reseller/ Distributor · 5 July 2022Pharmadule delivers turnkey modular facilities to EIPICO for biological and biosimilar manufacturing. The EIPICO-3 facility is the first and largest factory in Egypt and the Middle East to produce biologicals and biosimilars. EIPICO's Chairman and Managing Director Ahmed Kelani praised Pharmadule as a 'success partner', emphasizing highest standards and paving the way for future collaboration.
• Morimatsu International Holdings Ltd.flagshipOthers · 28 June 2021Morimatsu International Holdings Ltd. (Stock Code: 2155) is the parent company listed on the Main Board of The Stock Exchange of Hong Kong Limited since June 28, 2021. Pharmadule Morimatsu AB has been part of Morimatsu Group since 2011. The group is a world leader in innovative process solutions and modular facilities.
• GE Healthcare Life SciencescoreStrategic or Co-development Partner · 12 December 2019Long-standing collaboration with GE Healthcare Life Sciences in water treatment, medical equipment, aseptic preparation systems, and modular facilities. Pharmadule provides engineering design, construction, installation, and validation services for GE's proprietary KUBio manufacturing facility. GE management has given high recognition to Pharmadule's quality and project execution (awarded highest honor among 50,000 GE suppliers).
• Lonza (Guangzhou)majorStrategic or Co-development Partner · 12 December 2019Pharmadule provided KUBio modular facility design and fabrication for Lonza's state-of-the-art biopharma site in Guangzhou, China. The KUBio facility was built by GE Healthcare Life Sciences and incorporates GE's proprietary design. Project completed on time after 11 months of smooth execution including design, procurement, fabrication, transportation and module setting.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• G-CON Manufacturing: G-CON Manufacturing designs and produces prefabricated modular cleanroom PODs for pharmaceutical and biopharmaceutical manufacturing. It is the closest direct competitor to Pharmadule in off-site modular facility delivery, serving overlapping Big Pharma customers with comparable turnkey solutions.
• AES Clean Technology: AES Clean Technology specializes in modular cleanroom and facility solutions for life sciences, including cell and gene therapy and biopharma clients. It competes head-to-head with Pharmadule in off-site fabricated cleanroom delivery and rapid GMP deployment.
• NNE: NNE is a global engineering and consulting firm dedicated to pharma and biotech, providing facility design, engineering, and project execution services. It overlaps directly with Pharmadule's front-end design, commissioning, qualification, and validation services for GMP facilities.
• CRB Group: CRB is a leading engineering, architecture, and construction firm serving the life sciences industry with full project lifecycle services. It competes with Pharmadule in pharma facility design and delivery, particularly for advanced therapy and biologics manufacturers.
• IPS (Integrated Project Services): IPS provides engineering, architecture, construction, and validation services for GMP manufacturing facilities in pharma and biotech. Its integrated EPCMV model overlaps directly with Pharmadule's end-to-end modular facility and CQV services.
• Dockweiler AG: Dockweiler AG is a German specialist in stainless steel process equipment, modular process skids, and cleanroom process systems for the pharma and semiconductor industries. It is a comparable modular process equipment and clean facility fabrication peer to Pharmadule's Morimatsu-linked offerings.

Broad incumbents

• Jacobs Solutions: Jacobs is a global professional services firm with major life sciences engineering and construction capabilities serving pharma clients. It competes broadly in pharma facility design and construction but is not specialized in modular off-site delivery the way Pharmadule is.
• Cytiva: Cytiva (Danaher) provides bioprocess equipment, consumables, and facility solutions for biologics manufacturing. Its modular factory offerings and bioprocess focus overlap with Pharmadule's process modules and Bioengineering AG bioreactor capabilities.
• Sartorius AG: Sartorius is a leading international supplier of bioprocess equipment and single-use systems for pharma and biotech manufacturing. Its single-use bioreactors and process platforms are comparable to Pharmadule's modular process equipment and Bioengineering bioreactor portfolio.
• Fluor Corporation: Fluor is a global engineering, procurement, fabrication, and construction company with a sizable life sciences practice delivering pharma and biotech manufacturing facilities. It competes with Pharmadule as an EPCM alternative for large pharma capex projects.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharmadule-morimatsu

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmadule